GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Book Value per Share

Sphere Medical Holding (LSE:SPHR) Book Value per Share : £0.04 (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Book Value per Share?

Sphere Medical Holding's book value per share for the quarter that ended in Dec. 2016 was £0.04.

During the past 12 months, Sphere Medical Holding's average Book Value Per Share Growth Rate was -41.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -32.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -29.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Sphere Medical Holding was 10.90% per year. The lowest was -42.30% per year. And the median was -24.65% per year.

Sphere Medical Holding's current price is £0.00. Its book value per share for the quarter that ended in Dec. 2016 was £0.04. Hence, today's PB Ratio of Sphere Medical Holding is 0.00.

During the past 9 years, the highest P/B Ratio of Sphere Medical Holding was 5.35. The lowest was 0.07. And the median was 1.66.


Sphere Medical Holding Book Value per Share Historical Data

The historical data trend for Sphere Medical Holding's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Book Value per Share Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Book Value per Share
Get a 7-Day Free Trial Premium Member Only 0.13 0.15 0.06 0.08 0.04

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.06 0.09 0.08 0.06 0.04

Competitive Comparison of Sphere Medical Holding's Book Value per Share

For the Medical Devices subindustry, Sphere Medical Holding's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's PB Ratio falls into.



Sphere Medical Holding Book Value per Share Calculation

Sphere Medical Holding's Book Value Per Share for the fiscal year that ended in Dec. 2016 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6.21-0.00)/141.76
=0.04

Sphere Medical Holding's Book Value Per Share for the quarter that ended in Dec. 2016 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6.21-0.00)/141.76
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Sphere Medical Holding  (LSE:SPHR) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Sphere Medical Holding Book Value per Share Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.